Sanofi - American Depositary Shares (NQ:SNY)

39.92 UNCHANGED

Delayed Quote Updated: 4:00 PM EDT, Oct 2, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Sanofi - American Depositary Shares

< Previous 1 2

...

17 18 19 20 21 22 23 24 25

...

42 43 Next >

This Stock Just Dropped By 15%: Is It a Buy? ↗

November 03, 2023

Now could be a great opportunity to buy low.

Via The Motley Fool

Get Ready for Next Generation of Diabetes, Weight-Management Drugs

November 01, 2023

Via Investor Brand Network

Get Ready for Next Generation of Diabetes, Weight-Management Drugs

November 01, 2023

EQNX::TICKER_START (NASDAQ:LEXX),(NYSE:JNJ),(NYSE:SNY),(NASDAQ:AMGN),(NYSE:NVS) EQNX::TICKER_END

Via FinancialNewsMedia

Is NASDAQ:SNY a Good Fit for Dividend Investing? ↗

October 31, 2023

Is SANOFI-ADR (NASDAQ:SNY) a Good Fit for Dividend Investing?

Via Chartmill

Apple, AMD, Palantir Earnings On Deck This Week As Market Seeks Positive Catalysts In Fed Decision Week ↗

October 30, 2023

S&P 500 earnings is expected to grow in Q3, reversing a four-quarter slide, as the reporting season enters its third week.

Via Benzinga

Topics Economy Stocks

Sanofi Crashes 16% As Third Quarter Comes In Light Ahead Of Spinoff ↗

October 27, 2023

The company announced plans to spin off its consumer health division.

Via Investor's Business Daily

Looking Into Sanofi's Recent Short Interest ↗

October 26, 2023

Via Benzinga

Investor patience tested as pharmaceutical stocks take a tumble

November 01, 2023

The healthcare sector faces a selloff as pharmaceutical giants report lackluster earnings; even Amgen's strong results failed to prevent selling in the sector

Via MarketBeat

Why Is Gene Therapy Company MeiraGTx Stock Trading Higher Today? ↗

October 30, 2023

MeiraGTx Holdings plc (NASDAQ: MGTX) shares are trading higher after French pharma giant Sanofi SA (NASDAQ: SNY) made a $30 million

Via Benzinga

Sanofi (SNY) Q3 2023 Earnings Call Transcript ↗

October 27, 2023

SNY earnings call for the period ending September 30, 2023.

Via The Motley Fool

Topics Earnings

12 Health Care Stocks Moving In Friday's Intraday Session ↗

October 27, 2023

Via Benzinga

Stock Market Correction Intensifies; Google, Meta, Microsoft, Amazon Are Big Earnings Movers: Weekly Review ↗

October 27, 2023

Microsoft, Google, Amazon and Meta led big earnings.

Via Investor's Business Daily

Why Barnes Group Shares Are Trading Lower By Around 28%? Here Are Other Stocks Moving In Friday's Mid-Day Session ↗

October 27, 2023

Gainers Apollomics, Inc. (NASDAQ: APLM) shares surged 88.4% to $1.07 stoma multiforme with PTPRZ-MET fusion.

Via Benzinga

Why Are Stocks Up Today? ↗

October 27, 2023

Stocks are up on Friday as investors react to a positive earnings report from Amazon that has other tech stocks moving in sympathy with AMZN.

Via InvestorPlace

Why Is Nikola (NKLA) Stock Up 4% Today? ↗

October 27, 2023

Nikola stock is on the rise Friday as shares of NKLA continue a climb this week on positive news of $165 million award from a court case.

Via InvestorPlace

Preview: Sanofi's Earnings ↗

October 26, 2023

Via Benzinga

SNY Stock Sinks 15% as Sanofi Plans Consumer Unit Spinoff ↗

October 27, 2023

The happy talk in Sanofi's press release didn't help with analysts, who have been disappointed in the company and SNY stock all year.

Via InvestorPlace

12 Health Care Stocks Moving In Friday's Pre-Market Session ↗

October 27, 2023

Via Benzinga

Why Intel Shares Are Trading Higher By Around 8%; Here Are 20 Stocks Moving Premarket ↗

October 27, 2023

Gainers NKGen Biotech, Inc. (NASDAQ: NKGN) shares surged 60.9% to $6.08 in pre-market trading after gaining 8% on Thursday. NKGen Biotech presented Phase I clinical trial data at the 16th Annual...

Via Benzinga

Sanofi Goes The Rival Way: Plans Separation Of Consumer Healthcare Unit ↗

October 27, 2023

Sanofi SA (NASDAQ: SNY) plans to spin off its consumer healthcare business as the French pharmaceutical company outlined its strategic update to increase investment in its drug-development pipeline and...

Via Benzinga

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday ↗

October 27, 2023

It's time to start off the final trading day this week with a breakdown of the biggest pre-market stock movers on Friday!

Via InvestorPlace

Nasdaq, S&P 500 Eye Rebound While Bitcoin Edges Down: Amazon's Q3 Lifts Tech Stocks As Traders Eye Fed's Favorite Inflation Gauge ↗

October 27, 2023

As Amazon, Inc. (NASDAQ:AMZN) hawked good tidings, the negative sentiment in the equity market appears to have reversed. The recovery could be in part due to traders looking for bargains following a...

Via Benzinga

Topics Economy Stocks

Ford, Sanofi, Enphase Energy And Other Big Stocks Moving Lower In Friday's Pre-Market Session ↗

October 27, 2023

U.S. stock futures traded higher this morning on Friday. Here are some big stocks recording losses in today’s pre-market trading session.

Via Benzinga

Acurx Pharmaceuticals Share Price And Volume Are Surging Ahead Of Phase 2b Trial Data Release ($ACXP)

October 27, 2023

Via AB Newswire

Topics Death

Earnings Scheduled For October 27, 2023 ↗

October 27, 2023

Companies Reporting Before The Bell • Sanofi (NASDAQ:SNY) is projected to report quarterly earnings at $2.26 per share on revenue of $12.56 billion.

Via Benzinga

Sanofi Stock Relative Strength Rating Jumps To 84: One To Watch ↗

October 24, 2023

Additionally, Sanofi stock has a decent 83 Composite Rating out of 99, and an 80 Earnings Per Share Rating.

Via Investor's Business Daily

Why the Relapsed/Refractory Acute Myeloid Leukemia Market is Expected to Witness Revolutionary Developments

October 24, 2023

EQNX::TICKER_START (NASDAQ:TCBP),(NYSE:CVM),(NASDAQ:INVO),(NASDAQ:SNY),(NYSE:PFE) EQNX::TICKER_END

Via FinancialNewsMedia

Roche Spends $7.1 Billion On Roivant Drug, Following Merck, Sanofi Into The Raging Hot Immunology Space ↗

October 23, 2023

Roche is joining Merck and Sanofi in the TL1A drug space. These drugs could treat stomach diseases.

Via Investor's Business Daily

Amazon, Alphabet, Meta, Intel Q3 Earnings This Week: Will Mega-Caps Shatter Forecasts And Revive Market? ↗

October 23, 2023

Factset data indicates that out of the 17% of the S&P 500 companies that have reported so far, 73% have reported positive EPS surprises.

Via Benzinga

Topics Stocks

Dupixent® (dupilumab) Phase 3 Results Show Sustained Efficacy for Up to One Year in Children 1 to 11 Years of Age with Eosinophilic Esophagitis (EoE)

October 22, 2023

From Regeneron Pharmaceuticals, Inc.

Via GlobeNewswire

< Previous 1 2

...

17 18 19 20 21 22 23 24 25

...

42 43 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.